3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
17
Fallopian Tube Neoplasms
17
Glioblastoma
7
Colorectal Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Lung Neoplasms
6
Carcinoma, Renal Cell
6
Brenner Tumor
6
Melanoma
5
Uterine Cervical Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Gliosarcoma
4
Breast Neoplasms
4
Brain Neoplasms
4
Triple Negative Breast Neoplasms
3
Recurrent Squamous Cell Lung Carcinoma
3
Oligodendroglioma
3
Neoplasm Metastasis
3
Lymphoma, Large B-Cell, Diffuse
3
Colonic Neoplasms
3
Uveal Melanoma
2
Spinal Cord Neoplasms
2
Rectal Neoplasms
2
Prostatic Neoplasms
2
Medulloblastoma
2
Glioma
2
Endometrial Adenocarcinoma
2
Carcinoma
2
Astrocytoma
2
Adenocarcinoma of Lung
2
Interventions
lutetium Lu 177 dotatate
2
pembrolizumab
1
pasireotide
1
lanreotide
1
folfirinox
1
copper dotatate CU-64
1
arginyllysine
1
Receptor-Like Protein Tyrosine Phosphatases, Class 2
1
Octreotide
1
Nivolumab
1
Lutetium-177
1
Lutetium
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Etoposide
1
Cytokines
1
Cryotherapy
1
Carboplatin
1
Acupuncture Therapy
1
Acupressure
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Gastro-enteropancreatic neuroendocrine tumor
×
Disulfides
×
Clear all
No trials found.